PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25726N0225CTX BLOOD products IDIQ 04 01 — Carter Bloodcare

Carter Bloodcare holds $5.3M across 11 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 2 related awards under parent 36C25723D0035. Recompete timing centers on the Mar 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

257-Network Contract Office 17 (36C257)

Awarding office

Carter Bloodcare

Recipient

Mar 31, 2027

PoP end

$483K

Obligated

$483K

Potential

621991

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Carter Bloodcare — $90

Contract facts

Federal

Contract number36C25726N0225

Also listed as36C257-26-N-0225

Also listed as36C25723D0035-36C25726N0225

Agency257-Network Contract Office 17 (36C257)

Awarding office257-Network Contract Office 17 (36C257)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentCarter Bloodcare

CAGE318U5

UEIRFL7D3RDNTN3

NAICS621991

No full NAICS 621991 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36C25723D0035

Place of performanceTEMPLE TX

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

PoP startApr 1, 2026

PoP end (current)Mar 31, 2027

Obligated$483K

Current value$483K

Potential value$483K

CTX BLOOD PRODUCTS IDIQ 04/01/2023-03/31/2028 is a federal award for 257-Network Contract Office 17 (36C257) held by Carter Bloodcare. Estimated value $483K ($483K obligated). Current period of performance ends Mar 31, 2027. Place of performance: TEMPLE TX.

CTX BLOOD PRODUCTS IDIQ 04/01/2023-03/31/2028

Recompete timing

Public

● Expiring in 222 days

Current PoP ends Mar 31, 2027 (222 days remaining). Agencies typically plan 12–18 months ahead — at 7.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Carter Bloodcare — $5.3M obligated across 11 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($5.3M) · all agencies

Department of Veterans Affairs (VA)$4.8M · 91%Department of Defense (DOD)$550K · 10%

Open full company profile →

Related awards

Same parent · incumbent

36C25726N0141

BLOOD AND BLOOD PRODUCTS FOR NTX VA ADD TARIFF SURCHARGE

$1.9M

Apr 30, 2027

36C25725N0173

CTX BLOOD PRODUCTS IDIQ 04/01/2023-03/31/2028

$475K

Mar 31, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25726N0225?

36C25726N0225 (CTX BLOOD products IDIQ 04 01) is a 257-Network Contract Office 17 (36C257) award with a potential value of $483K, currently held by Carter Bloodcare. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C257-26-N-0225?

36C257-26-N-0225 is the dashed form of PIID 36C25726N0225 (CTX BLOOD products IDIQ 04 01), held by Carter Bloodcare. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25726N0225?

257-Network Contract Office 17 (36C257) awarded 36C25726N0225 to Carter Bloodcare (potential $483K).

Who is the incumbent on 36C25726N0225?

Carter Bloodcare is the incumbent with $5.3M across 11 related awards in SCOUT’s public footprint. The current period of performance ends Mar 31, 2027.

When does Carter Bloodcare’s 36C25726N0225 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Feb 10, 2026